4-phenylbutyric acid has been researched along with tretinoin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Calleja, E; He, LZ; Pandolfi, PP; Richon, V; Warrell, RP | 1 |
| Waxman, S | 1 |
| Warrell, RP | 1 |
| Chung, YL; Lin, CH; Sheu, ML; Yang, SC; Yen, SH | 1 |
3 review(s) available for 4-phenylbutyric acid and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Differentiation therapy in acute myelogenous leukemia (non-APL).
Topics: Acute Disease; Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Differentiation; Cholecalciferol; Chromatin; Drug Design; Drug Synergism; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Ligands; Mice; Middle Aged; Oncogene Proteins, Fusion; Phenylbutyrates; Transcription, Genetic; Translocation, Genetic; Tretinoin | 2000 |
Arsenicals and inhibitors of histone deacetylase as anticancer therapy.
Topics: Acetylation; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; China; Chromatin; Drug Evaluation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gastrointestinal Diseases; Histone Deacetylase Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Melarsoprol; Neoplasm Proteins; Neoplasms; Nervous System Diseases; Oxides; Phenylbutyrates; Protein Processing, Post-Translational; Salvage Therapy; Tretinoin | 1999 |
3 other study(ies) available for 4-phenylbutyric acid and tretinoin
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.
Topics: Acetylation; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Drug Administration Schedule; Female; Fluorescent Antibody Technique; Histone Deacetylases; Humans; Leukemia, Promyelocytic, Acute; Phenylbutyrates; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Tretinoin | 1998 |
Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Membrane; Cell Nucleus; Cell Separation; Cytosol; DNA Fragmentation; Down-Regulation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Immunohistochemistry; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; Phenylbutyrates; Precipitin Tests; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Retinoic Acid; Subcellular Fractions; Tamoxifen; Time Factors; Tretinoin; Tumor Cells, Cultured | 2002 |